Alvotech (ALVO) Interest & Investment Income (2021 - 2026)
Alvotech's (ALVO) quarterly Interest & Investment Income came in at -$16.4 million in Q2 2026, down 171.54% on a YoY basis from $22.9 million in Q2 2025, and down 149.11% quarter-over-quarter from $33.4 million in Q1 2026.
Analysis
Alvotech (ALVO) Interest & Investment Income (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Interest & Investment Income for 6 consecutive years, with -$16.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income fell 171.54% year-over-year to -$16.4 million; the trailing twelve-month figure through Jun 2026 stood at $187.7 million (up 26.33% YoY), and the FY2025 full-year result was $198.5 million, up 147.67% from the prior year.
- Interest & Investment Income fell to -$16.4 million in Q2 2026 per ALVO's latest filing, from $33.4 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $149.2 million in Q4 2025 and bottomed at -$41.6 million in Q4 2023.
- Historically, Interest & Investment Income has averaged $43.2 million across 5 years, with a median of $28.2 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income plunged 181.54% in 2023, then soared 16031.29% in 2025.
- Over 5 years, Interest & Investment Income stood at $51.0 million in 2022, then slumped by 181.54% to -$41.6 million in 2023, then surged by 102.56% to $1.1 million in 2024, then surged by 13900.66% to $149.2 million in 2025, then slumped by 111.0% to -$16.4 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$16.4 million, $33.4 million, and $149.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.09 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.12 Bn | 18.23 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 31.57 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | -55.04 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 530.13 Mn | 2.10 Bn | 11.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -16.41 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -3.64 Mn |
| 8 | Amphastar Pharmaceuticals | 991.81 Mn | 701.69 Mn | 93.47 Mn | 2.29 Mn |
| 9 | Fennec Pharmaceuticals | 412.12 Mn | 370.87 Mn | 17.15 Mn | 287,000.00 |
| 10 | RedHill Biopharma | 182.76 Mn | 182.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.41 Mn |
| Mar 31, 2026 | 33.41 Mn |
| Dec 31, 2025 | 149.25 Mn |
| Sep 30, 2025 | 21.44 Mn |
| Jun 30, 2025 | 22.94 Mn |
| Mar 31, 2025 | 126.31 Mn |
| Dec 31, 2024 | 1.07 Mn |
| Sep 30, 2024 | -1.74 Mn |
| Jun 30, 2024 | 80.04 Mn |
| Mar 31, 2024 | 783,000.00 |
| Dec 31, 2023 | -41.56 Mn |
| Aug 31, 2023 | 122.48 Mn |
| Jun 30, 2023 | 121.25 Mn |
| Mar 20, 2023 | 4.82 Mn |
| Dec 31, 2022 | 50.97 Mn |
| Aug 31, 2022 | 50.97 Mn |
| Jun 30, 2022 | 48.42 Mn |
| Mar 20, 2022 | 2.55 Mn |
| Dec 31, 2021 | 51.56 Mn |
| Sep 30, 2021 | 3,000.00 |